Various recent studies reveal that many autoinflammatory syndromes result from inflammasome related protein abnormality. Some inflammasomes closely correlate with caspase 1. Caspase 1 is a key molecule for activation of IL-1β, which is responsible for induction and augmentation of inflammation. Inflammatory cytokines, including IL-1β, are necessary for T H 17 differentiation from T H 0 cell. T H 17 cells were recently reported to play major roles in autoantibody production. In this point of view, inflammasome inducing inflammation participates in prominent roles both in autoinflammatory syndromes and autoimmunity. On the other hand, non-immunological ischemic injury deeply correlates with immunological reaction in kidney transplantation. Inflammation would share significant part both in non-immunological tissue destruction and immunological reaction of rejection in kidney transplantation. Inflammatory cytokines, including IL-1β, and chemokines are key regulators in progression of inflammatory reaction in ischemic kidney injury. Our data indicate that specific chemokines or chemokine receptors participate in specific pathologic changes at specific time points in the injury. One of some molecules, which work for these pathological changes would be new therapeutic targets for transplantation.
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Inflammasome in autoinflammation
Various types of autoinflammatory syndromes with hereditary periodic fever without any infection were reported since the end of 1990 1) . Many of them were demonstrated genomic abnormality (Table 1) . Mendelian autoinflammatory diseases were reported to be involved in pyrin 2, 3) . Cryopyrin were found to cause the autosomal dominant disorders familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS) in 2001 4) . Mutations in the same gene were identified in patients with neonatalonset multisystem inflammatory disease (NOMID) in 2002 5) . Mutations in the p55 TNF receptor led to TNF receptorassociated periodic syndrome (TRAPS) in 1999 6) . Moreover. Recent study revealed that the deficiency of the IL-1 receptor antagonist might one of causes of patients with autoinflammatory syndrome 7) .
Parallel with these certification of genetic abnormality, interaction of these molecules was investigated. Inflammasome is an intra cellular molecular complex for inflammation. Inflammasome was shown to activate caspase-1 and promote interleukin-1β (IL-1β) maturation 8) . IL-1β is a well-known player in the process of inflammation and fever. Moreover, hereditary autoinflammatory syndromes are characterized by an increased IL-1β production that directly triggers the inflammatory cascade in these patients. Therefore, the central role of IL-1β in pathogenesis of autoinflammatory syndromes was highlighted. Furthermore, inflammasome contains various kinds of protein including NALP family 9) . Those family genes recently reported to be main causes of autoinflammatory syndromes.
As well as IL-1β production, inflammasome participate in a special type of cell death, pyroptosis 10, 11) . Pyroptosis is a pathway to cell death mediated by the activation of inflammasome with caspase-1, and the inflammatory cytokines, such as IL-1β. That is pyroptosis features cell lysis with releasing inflammatory cellular contents, and induces inflammation around the dead cell. Therefore, pyroptosis would participate in pathogenesis of autoinflammatory syndromes 12) .
Inflammation and autoimmunity
Inflammation, as well as existence of autoantibody, is one of a key feature of autoimmune disease. IL-6 and IL-1β are pleiotropic and proinflammatory cytokines secreted by macrophages, Dendritic cells, T cells, and tubular epithelial cells, and exerts manifold effects in T cell differentiation. Both of IL-1β and IL-6 are also important factors for pathogenesis in various autoimmune dis- 14) . TH17 cells may lead to the induction of latent inflammatory TH17 response and hyper-activation of B cells, and may participate in production of autoreactive Abs 14) . TH17 induces autoimmunity in experimental models, and in genetically-predisposed individuals, that may assign TH17 cell lineage as a hallmark for autoimmunity 13) (Table 2 ). In this point, inflammatory cytokines including IL-1 and IL-6 would be important mediators for induction of autoimmune diseases ( Figure  1 ). Rheumatoid arthritis is a most common autoimmune disease. Recently, proinflammatory cytokines were highlighted as key therapeutic targets for rheumatoid arthritis 15) . It was reported that chronic inflammatory arthropathy resembling rheumatoid arthritis was developed in interleukin 1 receptor antagonist-deficient mice 16) . Moreover, various kinds of cytokines were detected in synovial tissue and fluid 17) . Biological agents targeting to these cytokines were clinically used, and showed high good responsiveness 18) . Using these biological agents, therapeutic strategy of rheumatoid arthritis management has been dramatically changed in the last 10 years. These biological agents apparently inhibit structural destruction and improve physical function and quality of life in RA patients. Although agents target only one molecule, such as TNF-a or IL-6, the agent largely affects their disease activity. These data indicated that one inflammatory molecule would be key regulator in autoimmune disease.
Table1. Inflammasome related autoinflammatory syndromes
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Inflammation and immunological reaction ---Ischemic injury and transplant immunology in kidney---
Total allograft rejection rate in kidney transplantation was apparently prevented year after year by immunosupression therapy. However, the total prevention mainly depends on prevention of acute rejection. Chronic rejection rate is almost similar around 30 years ago. Recent paper reveals that ischemic time is a key factor for allograft rejection in kidney transplantation 19) . These data indicate that non-immunological ischemic injury induces immunological reaction of allograft rejection. In this point of view, the inflammation on ischemic kidney injury is key reaction to understand transplant immunology.
One important point is how inflammatory reaction induces after ischemic injury. At least three ways of reaction induce inflammatory responses after ischemic kidney injury. The first way of the reaction is adenosine triphosphate (ATP) depletion. ATP depletion induces mitochondrial swelling. Injured mitochondria releases activated caspase 1, and activated caspase 1 cleaves IL-1β. IL-1β is an exponent pro-inflammatory cytokine, and can induce chemokines, such as keratinocyte-induced chemoattractant (KC), macrophage inflammatory protein (MIP)--1α or CCL5 / RANTES, from renal tubular epithelial cells 20) . The second way of the reaction that mediates ischemia-induced inflammation in the kidney is hypoxia inducible factor (HIF)-1. HIF-1 is just stable and works under hypoxic condition 21) . Many genes encoded for inflammatory cytokines and growth factors are induced by HIF-1 activation 22) . The third molecular switch linking ischemia to inflammation involves oxygen-derived free radicals. These molecules Involvement of inflammation in autoinflammation and autoimmune disease also induce TNF-α production by activating p38 mitogen-activated protein kinase (MAPK) 23) . Gathering all these three mechanisms induces inflammation after ischemic kidney injury.
Table2. TH17 related autoimmune diseases
•Multiple sclerosis (MS) and EAE
•Psoriasis-like dermatitis 
. Inflammatory cascades in ischemic kidney injury
At least three ways of reaction induce inflammatory responses after ischemic kidney injury; ATP depletion, HIF-1 induction, and oxygen free radical. Tubular epithelial cell producing pro-inflammatory cytokines augment inflammation after renal ischemic kidney injury.
Pro-inflammatory cytokines augment inflammation after renal ischemic kidney injury. Tubular epithelial cell appears to be the very sensitive to hypoxic conditions, and the cell has potential to produce various kinds of chemokines (e.g. CCL2/MCP-1, CCL5/ RANTES, CXCL8/IL-8, CXCL1/growth-regulated oncogene (GRO)). A large number of chemokines and chemokine receptors were expressed on tubular epithelial cells after ischemic kidney injury. The CXC chemokines, such as KC, CXCL2/3MIP-2 and CXCL8/IL-8, are upregulated in tubular epithelial cells after ischemic kidney injury, and this result in marked neutrophil infiltration 24,,25) . Therefore, CXCR2, a receptor for KC, CXCL2/3MIP-2 and CXCL8/IL-8, is one of a key molecule for neutrophil infiltration in a mouse model of ischemic kidney injury 24) , and these inflammatory cell infiltration augments inflammatory reaction after ischemic non-immunological injury (Figure 2) .
Chemokines are able to activate many different cell types, including leukocytes and renal parenchymal cells. Similarly to CXC chemokine, CC chemokines also upregulated after ischemic injury with marked monocyte/macrophage infiltration. Macrophage depletion with clodronate in vivo has supported a major role of monocyte/macrophage in pathogenesis of ischemic kidney injury 26) . Expression of the monocyte-targeted CC chemokine CCL2/MCP-1 is induced in ischemic kidney 27) . Both genetic deletion and pharmacological blockade of CCR2, the specific receptor for CCL2/MCP-1, have been reported to significantly reduce macrophage infiltration and tubular necrosis after ischemic injury 27, 28) . Immunohistological studies indicate that the main resident cell producing CCL2/MCP-1 in the kidney after ischemic injury is located in the distal tubule 29) . Macrophages are also a major source for CCL2/MCP-1, and for the inflammatory cytokines TNF-α, IL-1 and IL-6 30) . Therefore, these MCP-1/CCR2 positive feedback loops augment inflammatory reaction after ischemic kidney injury and might participate immunological reaction (Figure 3 ). As well as CCL2/MCP-1 regulated macrophage infiltration in tubular necrosis, our data indicated that interferon-gamma inducible protein (IP)-10 producing macrophage participate regeneration of tubular epithelial cells, and CX3CR1 mediated macrophage and Involvement of inflammation in autoinflammation and autoimmune disease platelet infiltration and aggregation play some roles in interstitial fibrosis in chronic kidney disease (Figure 3 ). All these inflammatory reaction might participate in immunological responses after ischemic kidney injury. Therefore, these chemokines and chemokine receptors on infiltrating inflammatory cells in ischemic injured kidney would be novel therapeutic targets of immunological reaction in kidney transplantation.
Conclusion
Inflammasome related inflammatory reaction would share important parts in pathogenesis of autoinflammatory syndrome, autoimmune diseases, and immunological reaction in transplantation.
